or
forgot password

    • cancer clinical trials in alexandria, LA

    • Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Prostate Cancer
    Levofloxacin in Preventing Infection in Young Patients Receiving Chemotherapy For Acute Leukemia or Undergoing Stem Cell Transplantation
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Bacterial Infection, Leukemia, Musculoskeletal Complications, Neutropenia
    Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer
    Christus St. Frances Cabrini Hospital
    Alexandria, Louisiana 71301
    Breast Cancer
    Combination Chemotherapy in Treating Children With Progressive Brain Tumors
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Brain and Central Nervous System Tumors
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Melanoma (Skin)
    Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Gestational Trophoblastic Tumor
    Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Lymphoma
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Cabrini Center for Cancer Care
    Alexandria, Louisiana 71301
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Lymphoproliferative Disorder
    Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
    Christus St. Frances Cabrini Center for Cancer Care
    Alexandria, Louisiana 71301
    Breast Cancer, Lung Cancer, Neurotoxicity, Ovarian Cancer, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Neuroblastoma
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Brain Tumor, Central Nervous System Tumor
    Non-small Cell Lung Cancer Registry
    Cabrini Center for Cancer Care
    Alexandria, Louisiana 71301
    Non-Small-Cell Lung Cancer, Pleural Effusion, Malignant
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Brain and Central Nervous System Tumors
    Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
    Cabrini Center for Cancer Care/Christus St. Frances Cabrini Hospital
    Alexandria, Louisiana 71301
    Myelodysplastic Syndrome, Iron Overload
    Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer
    Cabrini Center for Cancer Care at Christus St. Frances Cabrini Hospital
    Alexandria, Louisiana 71301
    Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    Neo-adjuvant Gemcitabine, Epirubicin, ABI-007 (GEA) in Locally Advanced or Inflammatory Breast Cancer
    Hematology Oncology Life Center
    Alexandria, Louisiana 71301
    Breast Cancer
    A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
    Cabrini Center for Cancer Care
    Alexandria, Louisiana 71301
    NSCLC
    Vinflunine Plus Trastuzumab in HER2 Over-Expressing Metastatic Breast Cancer
    Hematology Oncology Life Center
    Alexandria, Louisiana 71301
    Breast Neoplasms, Breast Cancer
    Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer
    Hematology Oncology Life Center
    Alexandria, Louisiana 71301
    Small Cell Lung Cancer, Carcinoma, Small Cell
    Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer
    Hematology Oncology Life Center
    Alexandria, Louisiana 71301
    Breast Cancer
    Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer
    Hematology Oncology Life Center
    Alexandria, Louisiana 71301
    Carcinoma, Small Cell
    Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
    Alexandria Cardiology Clinic
    Alexandria, Louisiana 71301
    Atrial Fibrillation, Atrial Flutter
    Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Sarcoma
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia
    S0309, Collecting and Storing Blood and Bone Marrow Samples From Patients With Myeloma, Waldenstrom's Macroglobulinemia, Amyloidosis, or Monoclonal Gammopathy of Undetermined Significance
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition
    S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
    Tulane Cancer Center Office of Clinical Research
    Alexandria, Louisiana 71315-3198
    Multiple Myeloma, Plasma Cell Myeloma